Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

S. K. Kumar, B. Laplant, V. Roy, C. B. Reeder, M. Q. Lacy, M. A. Gertz, K. Laumann, M. A. Thompson, T. E. Witzig, F. K. Buadi, C. E. Rivera, J. R. Mikhael, P. L. Bergsagel, P. Kapoor, L. Hwa, R. Fonseca, A. K. Stewart, A. Chanan-Khan, S. V. Rajkumar, A. Dispenzieri

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib'. Together they form a unique fingerprint.

Medicine & Life Sciences